EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care

Maria Luisa Faquetti iD, Géraldine Frey, Dominik Stämpfli iD, Stefan Weiler iD, Andrea M Burden iD

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.16018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Maria Luisa Faquetti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences, Zurich, Switzerland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Primary Health Care, Polypharmacy, Inappropriate Prescribing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aim of this study was to estimate the prevalence of potentially inappropriate prescriptions (PIPs) in patients starting their first noninsulin antidiabetic treatment (NIAD) using two explicit process measures of the appropriateness of prescribing in UK primary care, stratified by age and polypharmacy status.

Methods

A descriptive cohort study between 2016 and 2019 was conducted to assess PIPs in patients aged ≥45 years at the start of their first NIAD, stratified by age and polypharmacy status. The American Geriatrics Society Beers criteria 2015 was used for older (≥65 years) patients and the Prescribing Optimally in Middle‐age People's Treatments criteria was used for middle‐aged (45‐64 years) patients. Prevalence of overall PIPs and individual PIPs criteria was reported using the IQVIA Medical Research Data incorporating THIN, a Cegedim Database of anonymized electronic health records in the UK.

Results

Among 28 604 patients initiating NIADs, 18 494 (64.7%) received polypharmacy. In older and middle‐aged patients with polypharmacy, 39.6% and 22.7%, respectively, received ≥1 PIP. At the individual PIP level, long‐term proton pump inhibitors (PPI) use was the most frequent PIP among older adults, and strong opioid without laxatives was the most frequent PIP in middle‐aged patients with polypharmacy (11.1% and 4.1%, respectively).

Conclusions

This study revealed that patients starting NIAD treatment receiving polypharmacy have the potential for pharmacotherapy optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Primary Health CarePolypharmacyInappropriate PrescribingHypoglycemic AgentsPotentially Inappropriate Medication ListHumansMiddle AgedAgedUnited KingdomFemaleMalePrevalenceCohort StudiesAge FactorsAged, 80 and overPractice Patterns, Physicians'

Stichwörter der Autor:innen

diabetes mellitus type 2inappropriate medicationinappropriate prescribingpolypharmacypotentially inappropriate medication listprimary healthcare

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences, Zurich, Switzerland.
  • Hospital Pharmacy, Kantonsspital Baden, Baden, Switzerland.
  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Maria Luisa Faquetti, Dominik Stämpfli, Stefan Weiler, Andrea M Burden

Zitieren

APA

Faquetti, M. L., Frey, G., Stämpfli, D., Weiler, S., & Burden, A. M. (2024). Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16018

Vancouver

Faquetti ML, Frey G, Stämpfli D, Weiler S, Burden AM. Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16018

BibTeX
@article{Faquetti2024,
  author = {Faquetti, Maria Luisa and Frey, Géraldine and Stämpfli, Dominik and Weiler, Stefan and Burden, Andrea M},
  title = {Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.16018}
}
Kostenlos starten →